Bratton Capital Management, L.P.'s Net Worth

$0

Estimate Recalculated Nov 7, 2024 11:43AM EST

Who is Bratton Capital Management, L.P.?

Bratton Capital Management, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Denali Therapeutics Inc., and Aquestive Therapeutics, Inc..

SEC CIK

Bratton Capital Management, L.P.'s CIK is 0001723787

Past Insider Trading and Trends

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Denali Therapeutics Inc. (DNLI) Snapshot price: $25.25

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-383.41K
—
—
0
Dec 21
Form 4
-14.42%
-64.62K
$80.14
-$5,179,284.87
383.41K
Dec 11 - Dec 14
Form 4
-35.81%
-250.00K
$23.97
-$5,993,051.59
448.04K
Jun 26 - Jun 30
Form 4
-26.76%
-255.00K
$24.72
-$6,304,373.01
698.03K
Jun 19 - Jun 23
Form 4
-14.28%
-158.76K
—
—
953.03K
Mar 25
Form 4
+6,483.78%
20.26M
$18.00
—
20.57M
Dec 12
Form 3
—
0
—
—
0
No matching records found

Aquestive Therapeutics, Inc. (AQST) Snapshot price: $4.25

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-15.16%
-1.75M
—
—
9.82M
Mar 9 - Mar 12
Form 4
∞
165K
$15.00
$2,475,000.00
165K
Jul 24
No matching records found